Tags |
|
|
Links |
|
|
Social Articles - Bush Administration and the Road to Alternative Fuels
Some of the political rhetoric from the opposing political pa
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
rty is quite alarming in that the Democrats are attacking the
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
Bush Administration for their alternative fuel views. Why is
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
his alarming? Well, because previously it was the Democrats,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
hich had plugged the alternative fuel use. But now since the
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ush Administration is working towards it, all of a sudden it
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
is called into question.
I completely approve of Bush's stro
I completely approve of Bush's stro
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
g leadership and taking his message on the Road and talking u
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
the great companies and research folks who are working on ef
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
icient, good ROI and sensible alternative energy concepts. An
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
one who condemns his alternative energy efforts now, is shoot
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ing themselves in the foot. I feel it is unfortunate to see B
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
sh haters who cannot bury the partisan politics hatchet long
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
nough to join forces in a common cause in doing the right thi
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
g with alternative energy sources.
We as a nation should not
We as a nation should not
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
allow ourselves to be so caught up in the sound and fury that
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
we cannot work together in a common cause for the betterment
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
of all. If we agree that alternative fuels make sense then we
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ought to agree to work together in a non-partisan way to make
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
it happen without attacking each other. Consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.socialarticles.org.ua/article/193400/socialarticles-Bush-Administration-and-the-Road-to-Alternative-Fuels.html">Bush Administration and the Road to Alternative Fuels</a>
BB link (for phorums):
[url=http://www.socialarticles.org.ua/article/193400/socialarticles-Bush-Administration-and-the-Road-to-Alternative-Fuels.html]Bush Administration and the Road to Alternative Fuels[/url]
Related Articles:
Beyond Demographics: Using Funnel Vision To Improve Your Marketing
Three Ways to Solve the Climate Crisis
Bookmark it:
|